CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells

dc.contributor.authorSokka, Joonas
dc.contributor.authorYoshihara, Masahito
dc.contributor.authorKvist, Jouni
dc.contributor.authorLaiho, Laura
dc.contributor.authorWarren, Andrew
dc.contributor.authorStadelmann, Christian
dc.contributor.authorJouhilahti, Eeva-Mari
dc.contributor.authorKilpinen, Helena
dc.contributor.authorBalboa, Diego
dc.contributor.authorKatayama, Shintaro
dc.contributor.authorKyttälä, Aija
dc.contributor.authorKere, Juha
dc.contributor.authorOtonkoski, Timo
dc.contributor.authorWeltner, Jere
dc.contributor.authorTrokovic, Ras
dc.date.accessioned2022-04-20T06:30:37Z
dc.date.available2022-04-20T06:30:37Z
dc.date.issued2022
dc.description.abstractConventional reprogramming methods rely on the ectopic expression of transcription factors to reprogram somatic cells into induced pluripotent stem cells (iPSCs). The forced expression of transcription factors may lead to off-target gene activation and heterogeneous reprogramming, resulting in the emergence of alternative cell types and aberrant iPSCs. Activation of endogenous pluripotency factors by CRISPR activation (CRISPRa) can reduce this heterogeneity. Here, we describe a high-efficiency reprogramming of human somatic cells into iPSCs using optimized CRISPRa. Efficient reprogramming was dependent on the additional targeting of the embryo genome activation-enriched Alu-motif and the miR-302/367 locus. Single-cell transcriptome analysis revealed that the optimized CRISPRa reprogrammed cells more directly and specifically into the pluripotent state when compared to the conventional reprogramming method. These findings support the use of CRISPRa for high-quality pluripotent reprogramming of human cells.
dc.format.mimetypeapplication/pdf
dc.identifier.citationSokka J, Yoshihara M, Kvist J, Laiho L, Warren A, Stadelmann C, Jouhilahti EM, Kilpinen H, Balboa D, Katayama S, Kyttälä A, Kere J, Otonkoski T, Weltner J, Trokovic R. CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells. Stem Cell Reports. 2022 Feb 8;17(2):413-26. DOI: 10.1016/j.stemcr.2021.12.017
dc.identifier.doihttp://dx.doi.org/10.1016/j.stemcr.2021.12.017
dc.identifier.issn2213-6711
dc.identifier.urihttp://hdl.handle.net/10230/52856
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofStem Cell Reports. 2022 Feb 8;17(2):413-26
dc.rights© 2021 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.keywordCRISPRa
dc.subject.keywordEEA
dc.subject.keywordLCL
dc.subject.keywordHuman
dc.subject.keywordiPSC
dc.subject.keywordmicroRNA
dc.subject.keywordmir-302/367
dc.subject.keywordReprogramming
dc.subject.keywordSingle-cell RNA sequencing
dc.subject.keywordTranscriptomics
dc.titleCRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion

Files

License

Rights